Dr. Victoria Wilkins, MD
Claim this profileUniversity of Utah and Primary Childrens Hospital
Studies Fragile X Syndrome
Studies Syndrome
3 reported clinical trials
6 drugs studied
Area of expertise
1Fragile X Syndrome
FMR1 positive
FMR1
2Syndrome
FMR1 positive
FMR1
Affiliated Hospitals
University Of Utah And Primary Childrens Hospital
Primary Children's Hospital
Clinical Trials Victoria Wilkins, MD is currently running
Zatolmilast
for Fragile X Syndrome
This trial is testing a medication called BPN14770 in boys with fragile X syndrome. The study aims to see how the medication moves through their bodies and if it helps with their symptoms.
Recruiting0 awards Phase 2 & 3
Cannabidiol Gel
for Fragile X Syndrome
This is a randomized, double-blind, placebo-controlled, multiple-center study, to assess the efficacy and safety of Cannabidiol administered as ZYN002 for the treatment of children, adolescent, and young adult patients with Fragile X Syndrome (FXS). Eligible participants will participate in up to an 18-week treatment period, where all participants will receive placebo or active study drug. Patients ages 3 to \< 30 years will be eligible to participate.
Recruiting1 award Phase 311 criteria
More about Victoria Wilkins, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Victoria Wilkins, MD has experience with
- Placebo
- ZYN002 - CBD Transdermal Gel
- ZYN002 - Transdermal Gel
- BPN14770/ Zatolmilast
- BPN14770
- Zatolmilast
Breakdown of trials Victoria Wilkins, MD has run
Fragile X Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Victoria Wilkins, MD specialize in?
Victoria Wilkins, MD focuses on Fragile X Syndrome and Syndrome. In particular, much of their work with Fragile X Syndrome has involved FMR1 positive patients, or patients who are FMR1.
Is Victoria Wilkins, MD currently recruiting for clinical trials?
Yes, Victoria Wilkins, MD is currently recruiting for 3 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Victoria Wilkins, MD has studied deeply?
Yes, Victoria Wilkins, MD has studied treatments such as Placebo, ZYN002 - CBD transdermal gel, ZYN002 - transdermal gel.
What is the best way to schedule an appointment with Victoria Wilkins, MD?
Apply for one of the trials that Victoria Wilkins, MD is conducting.
What is the office address of Victoria Wilkins, MD?
The office of Victoria Wilkins, MD is located at: University of Utah and Primary Childrens Hospital, Salt Lake City, Utah 84113 United States. This is the address for their practice at the University of Utah and Primary Childrens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.